Themes / Group
Active · newly observed relationshipLatest completed snapshot · 16:55 ET

MARKET-DISCOVERED GROUP

Medical Devices · IDXX

THE TRADER READShared activity without a clean directional read

Price direction is split across 12 measured members. Capital-flow confirmation is unavailable.

Price breadth8 up · 4 downRelative median unavailable
Capital-flow alignmentUnavailablePrice breadth is not yet confirmed by flow
Activity nowBuilding_pressureActivity score 34/100
Evidence depth0 support daysLow sample—context, not a validated playbook
EVIDENCE CLOCK

What happened, in timestamp order

1 timed event
TIMING READA causal timing read is unavailable because no material member price onset could be timestamped.
2 earlier filing context receipts

SUN, NOV 2IDXX filing documented shared operating contextdemand / volume affecting revenue · date precision only

THU, FEB 19ABT filing documented shared operating contextdemand / volume affecting revenue · date precision only

Headline times and retained activity confirmations are point-in-time evidence. Price order is inferred from aligned 5-minute bars. Filing evidence has date precision only and is context, not an intraday catalyst claim.

01 · WHAT IS HAPPENING

The move, the flow and who is driving it

Price breadth, unusual activity and signed capital flow are separate observations
Price sequence unavailableA timestamped price sequence is unavailable.
RELATIVE CO-MOVEMENT

How the members are behaving together

Session-normalized

Observed intraday paths are not available for this group yet.

02 · WHY IT MATTERS

Why now and where the move could travel

Context and lead/lag links are evidence, not proof of causation or a forecast
WHY THIS GROUP EXISTS

Shared filing context

11/12 members covered

Moderate filing support: the strongest shared 10-Q/K outlook is operating setup (near-term outlook) across BDX, IDXX, MDT, RMD, STE, TFX, VLTO, ZBH, ZTS.

demand / volume affecting revenue

“The increase in CAG Diagnostics recurring revenue was primarily due to higher volumes in IDEXX VetLab consumables and reference laboratory testing partially offset by macroeconomic and sector headwinds, as well as benefits from higher realized prices.”

IDXX 10-Q · 2025-11-03
product pipeline / R&D affecting expense

“Research and development expense increased primarily due to higher personnel-related costs.”

IDXX 10-Q · 2026-08-04
credit / rates affecting interest expense

“In addition, these alternatives could result in increased interest expense or other dilution of our earnings.”

IDXX 10-Q · 2026-08-04
CONFIRMATION NETWORK

Outsiders and cross-asset links

0 outsiders confirming
STE → UVXYPositive historical lead/lag · strength 0.33

Filing-linked outsiders test whether the move is spreading beyond the established cohort.

No high-confidence filing-linked outsiders are available for this group yet.

03 · WHO IS IN IT

Member participation

Unusual activity and daily price direction are shown separately
ZTSIDXXVLTOTFXMDTBDXSTESNNABTZBHRMDSOLV

8/12 active8 rising · 4 falling

MemberUnusual activityToday's moveRead now
ZTSZoetis Inc.
Elevated · 100/100
+1.4%
Active; unclassifiedHistorical role unavailable
IDXXIDEXX Laboratories, Inc.
Most unusual · 91/100
+1.3%
Active; unclassifiedHistorical role unavailable
VLTOVeralto Corporation
Elevated · 83/100
-0.8%
Active; unclassifiedHistorical role unavailable
TFXTeleflex Incorporated
Elevated · 81/100
-0.9%
Active; unclassifiedHistorical role unavailable
MDTMedtronic plc.
Elevated · 81/100
+1.6%
Active; unclassifiedHistorical role unavailable
BDXBecton, Dickinson and Company
Elevated · 71/100
-0.8%
Active; unclassifiedHistorical role unavailable
STESTERIS plc
Elevated · 63/100
+1.3%
Active; unclassifiedHistorical role unavailable
SNNSmith & Nephew plc
Quiet · 63/100
+1.6%
Watch / laggardHistorical role unavailable
ABTAbbott Laboratories
Quiet · 61/100
+2.1%
Watch / laggardHistorical role unavailable
ZBHZimmer Biomet Holdings, Inc.
Quiet · 61/100
+1.0%
Watch / laggardHistorical role unavailable
RMDResMed Inc.
Quiet · 58/100
-0.1%
Watch / laggardHistorical role unavailable
SOLVSolventum Corporation
Quiet · 45/100
+0.8%
Watch / laggardHistorical role unavailable
View exact member values
TICKERCompanyRole nowTodayObserved historyTrader interpretation
ZTSZoetis Inc.Participating+1.4%—Price participation is not yet confirmed by per-name flow.
IDXXIDEXX Laboratories, Inc.Most unusual+1.3%—Most unusual activity in this snapshot; performance direction may differ.
VLTOVeralto CorporationParticipating-0.8%—Price participation is not yet confirmed by per-name flow.
TFXTeleflex IncorporatedParticipating-0.9%—Price participation is not yet confirmed by per-name flow.
MDTMedtronic plc.Participating+1.6%—Price participation is not yet confirmed by per-name flow.
BDXBecton, Dickinson and CompanyParticipating-0.8%—Price participation is not yet confirmed by per-name flow.
STESTERIS plcParticipating+1.3%—Price participation is not yet confirmed by per-name flow.
SNNSmith & Nephew plcQuiet / lagging+1.6%—Not participating yet; a breadth test or a genuine divergence.
ABTAbbott LaboratoriesQuiet / lagging+2.1%—Not participating yet; a breadth test or a genuine divergence.
ZBHZimmer Biomet Holdings, Inc.Quiet / lagging+1.0%—Not participating yet; a breadth test or a genuine divergence.
RMDResMed Inc.Quiet / lagging-0.1%—Not participating yet; a breadth test or a genuine divergence.
SOLVSolventum CorporationQuiet / lagging+0.8%—Not participating yet; a breadth test or a genuine divergence.

04 · HAS THIS HAPPENED BEFORE

Identity history versus measured outcomes

Structural recurrence is not the same as a validated trading outcome
POINT-IN-TIME LIVE OUTCOMES

Live outcome ledger collecting

0/0 events completed

No completed point-in-time outcome is available yet. New live confirmations are now retained with their exact observation timestamp; statistics appear only after the corresponding candles complete.

No point-in-time live observations have completed yet.
Low structural sample

Only 0 completed episodes across 0 active sessions; treat history as context, not a validated playbook. These episode counts describe recurrence; the outcome ledger above is the only forward-performance evidence.

Structural support0 daysHow often the cohort identity was observed
Completed episodes0Separate periods of broad group activity
Active sessions0Completed session observations, not trades

Historical cohort observations are not available yet.